1. Home
  2. WVE vs BLZE Comparison

WVE vs BLZE Comparison

Compare WVE & BLZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$3.69

Market Cap

673.9M

Sector

Health Care

ML Signal

HOLD

Logo Backblaze Inc.

BLZE

Backblaze Inc.

HOLD

Current Price

$8.60

Market Cap

762.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
BLZE
Founded
2012
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
673.9M
762.0M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
WVE
BLZE
Price
$3.69
$8.60
Analyst Decision
Strong Buy
Buy
Analyst Count
21
7
Target Price
$17.11
★ $22.83
AVG Volume (30 Days)
★ 3.0M
1.8M
Earning Date
10-27-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 58.56
EPS
N/A
★ N/A
Revenue
$3,704,000.00
★ $145,835,000.00
Revenue This Year
$46.45
$18.60
Revenue Next Year
N/A
$25.89
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 149.43
14.27
52 Week Low
$3.04
$3.26
52 Week High
$21.73
$23.99

Technical Indicators

Market Signals
Indicator
WVE
BLZE
Relative Strength Index (RSI) 51.82 31.67
Support Level $3.04 $6.88
Resistance Level $4.07 $9.46
Average True Range (ATR) 0.20 0.82
MACD 0.10 -0.08
Stochastic Oscillator 76.83 9.92

Price Performance

Historical Comparison
WVE
BLZE

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About BLZE Backblaze Inc.

Backblaze Inc offers a cloud storage platform designed to help businesses and consumers store, use, and protect their data. The company delivers its services through the Backblaze Storage Cloud platform, a purpose-built, web-scale software architecture operating on commodity hardware. Backblaze's offerings include B2 Cloud Storage, an Infrastructure-as-a-Service (IaaS) solution, and Computer Backup, a Software-as-a-Service (SaaS) solution. Its customer base includes individuals, developers, MSPs, small and medium-sized businesses, and large enterprises across industries, academic institutions, government agencies, and other enterprises. Geographically, the company generates maximum revenue from its business in the United States, followed by the United Kingdom, Canada, and other markets.

Share on Social Networks: